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ABSTRACT 
DETERMINATION OF THE EFFECT OF DIFFERENT BLADE SPEEDS AND MIXING TIMES ON 
THE HOMOGENEITY OF MIXTURES CONTAINING DIFFERENT RATIOS OF TWO POWDERS 
Aim 
The first step in a wet granulation process is dry mixing. This step has the objective of ensuring that 
all the raw materials are mixed such that the end product is homogeneous. Dry mixing in a high shear 
mixer instead of a blender saves cost. However, the mixing parameters have not been well 
researched. Dry mixing parameters that are currently used, have been established through 
experience, trial and error and in-process testing. Alexander and Muzzio (2006) confirms this by 
stating that there are currently no mathematical techniques to predict blending behaviour of granular 
components without prior experimental work; therefore, blending studies start with a small-scale, try-it-
and-see approach. Even though they are referring to blending, the same is also true for dry mixing. 
Both processes are the mixing of powders. Therefore the aim of this research was to develop 
parameters for dry mixing, based on experimental work.  
Methods 
Using a Saral rapid mixer and wet granulator (Saral Engineering Company, India), experiments were 
performed according to a 24  two-level Plackett-Burman Design method, to determine the effects of 
different blades (mixer/impeller and chopper) speeds and mixing times on the homogeneity of the 
mixtures containing different ratios of two powders that have different densities and particle sizes. 
One of the powders mixed, was enalapril maleate. This was chosen as it can be assayed. Samples 
were taken from the bowl and tested for assay. The mix for a specific experiment is homogeneous if 
the results of all 7 assayed samples are within 10 % of the target % w/w value and the % Relative 
Standard Deviation (% RSD) of the 7 results is less than or equal to 5,0 %. The outcome was being 
measured in % RSD. A lower % RSD indicates a more homogeneous mix.  
The parameters developed, will be beneficial to pharmaceutical companies as it can assist them to 
improve accuracy, consistency and quality of granular mixes. The experimental method used can 
serve as an example for future experiments. 
iv 
Results 
The results indicated that impeller blade mixing speed and mixing time are the two factors that have 
the biggest impact on the homogeneity of a mix in a high shear mixer. Chopper blade speed was also 
found to be significant, but less than the above two parameters mentioned. Optimal parameters were 
predicted. 
Conclusion 
As there are many parameters to be controlled during dry mixing in a high shear mixer, a statistical 
design method is suitable to establish the parameters that would have the most impact on the end 
result. Statistically it was found that mixing speed of the main impeller and chopper blades and overall 
mixing time are the three factors that have the biggest impact on the homogeneity of a mixture. The 
mixing time and impeller blade speed have proven to be more significant than the chopper blade 
speed. Concentration was found to be insignificant. For our experiments and for the specific 
granulator used the following optimal parameters could be deduced: Impeller blade set at 191 rpm, 
chopper blade set at 2002 rpm and mixing time set at 3.01 minutes.  
Keywords: wet granulator, dry mixing parameters, blade speeds, 24  two-level Plackett-Burman 
Design method 
v 
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1. INTRODUCTION 
1.1 Background to research 
Tabletting entails compressing powders or a granule into a tablet. Encapsulation entails filling a 
capsule shell with powder or granules. Dry mixing is part of any granulation process. Dry mixing 
needs to be well understood, as well as all the factors influencing it. This mixing process has a critical 
impact on the content uniformity of the final product, whether a granule from a wet granulation 
process, dry powder for direct compression or roller compaction, or a dry powder for encapsulation. 
The purpose of dry mixing of powders before a wet granulation process is to get an even distribution 
of all the ingredients in the mixture, including the Active Pharmaceutical Ingredient (API) raw material 
in the powder mix, before adding the granulating medium to form a coherent and homogenous 
granule. This is to ensure that the final granules, which are compressed into tablets, contain the same 
amount of the API, so that the patient consistently consumes the required dose of API. It is also to 
ensure that all the Inactive Pharmaceutical Ingredients (IPI’s) are contained in the same amounts for 
the tableting procedure. Each ingredient in a mix has a specific purpose and the correct quantity 
should be in each tablet, for example if the disintegrant is not homogenously mixed, then the tablets 
might disintegrate at different rates, which could lead to different dissolution times and finally different 
levels of the medicine in the blood. The dry mixing of powders is an important operational step, 
because the accuracy of the API content of the tablets depends upon the efficiency of mixing of the 
dry powders before the wet granulation process takes place. Content uniformity of the final dosage 
form is dependent on the homogeneity of the powder mixture in the mixer/ blender. Alexander and 
Muzzio (2006) confirms this when stating that in the manufacture of many pharmaceutical products 
(especially tablets and capsules), dry particle blending is often a critical step that has a direct impact 
on content uniformity. This statement is further confirmed by Venables & Wells (2001) who state that 
mixing is the fundamental process in solid particulate dosage forms to ensure content uniformity and, 
in many cases, dissolution rate. 
Dry powders could be mixed manually in a trough, it could be mixed in a high shear mixer or it could 
be mixed in a blender before it is granulated. A satisfactory mixing process should produce a uniform 
mixture in minimum time and with minimum cost for overhead, power and labour (Barbosa-Cánovas 
et al., 2005). Wet granulation is used extensively in pharmaceutical industries. The popularity of wet 
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granulation is because it can be applied to all drugs, and for many formulators it is the method of 
choice for drugs with high doses and a very low dose (DFE Pharma 2013). In the pharmaceutical 
industry, most products are manufactured using the wet granulation process. More than 70 % of the 
global industry’s granulators are made using this method (Tousey 2002). Vojnovic et al. (1992) 
confirm the extensive use of wet granulation in their article titled “Wet Granulation in a small scale 
high shear mixer”. The three commonly used granulation methods include wet granulation, dry 
granulation, and hot-melt granulation (Gokhale & Trivedi 2010). Currently, particle blending is a key 
step in most industrial processes, especially in the manufacture of pharmaceuticals, where 80 % of 
drug products are sold as solid dosage forms (tablets and capsules) and subject to stringent FDA 
regulations on content uniformity (Sudah et al., 2002). 
The different stages of wet granulation includes: 
Dry mixing – wet granulation – drying – screening – blending 
By performing the dry mixing step in the same equipment in which the product is granulated, will save 
time in terms of equipment and operator labour. To use a blending system first for mixing and then 
discharge into a bowl of a high shear mixer/granulator to form granule, is more costly and time 
consuming than to perform the dry mixing and granulation steps in the same equipment. Numerous 
studies have been performed on dry mixing in blenders (for example: Bozzone 2001 and Ngai 2005), 
but very few have been performed on dry mixing in a high shear mixer/granulator. Since high shear 
mixers and blenders use different types of mixing (diffusion or convection versus shear), parameters 
are different and studies performed on one cannot be applied to the other equipment. Parameters in 
diffusion mixing would include the speed that the blender bin rotates. Diffusion mixing entails mobility 
of individual particles being increased. Particles are distributed over a freshly developed interface. 
Parameters in convection mixing would include the rotating speed of a paddle for example. 
Convection mixing entails a random motion of solid particles. Groups of particles are moved from one 
position in a mixer to another due to the cascading of materials within the equipment. Parameters in 
shear mixing include the speed that the impeller/mixer and chopper blades rotate. Shear mixing  
entails the development of slip planes within a bed of materials or the splitting of the bed of material to 
disintegrate agglomerates to overcome cohesion. In a shear mixer it is the impeller and chopper 
blades that rotate, whereas in diffusion mixing it is the bin itself and in convection mixing it is one 
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paddle or impeller that rotates. Principles that influence the mixing of powders can be applicable to 
both mixing systems, but the operating parameters will be different as a high shear mixer has blades 
which are not present in a blender. The reason for very little available literature on dry mixing 
parameters in high shear mixers might be because this step forms part of the development of a 
granule and is tested as an in-process step which becomes confidential information for a company.  It 
is a test that is done as part of experimentation and not as part of routine in-process testing. It is also 
because the parameters might be specific for each and every product. This project is an example of 
how optimal parameters for dry mixing in a high shear mixer can be established during the 
development phase, especially for a product where content uniformity is a challenge. Small tablets or 
tablets that has a low mass as well as a small percentage of API (low dose) in the tablets pose a 
challenge to content uniformity. An example would be enalapril tablets which have a weight of for 
example + 150 mg and a strength of 20 mg. Less than 15 % of the tablet mass is API. 
The position of the US Food and Drug Administration (US FDA) on blend testing is as follows: when 
mixing is critical, blend evaluation is warranted, but may be unnecessary under certain circumstances 
(FDA 2003). It is hence not compulsary to test a dry mix before wet granulation, but only after the 
blending step, which is when the granule and extra-granular material have been mixed together.  
Code of Federal Regulations (CFR) Title 21 (21 CFR 211.110) requires in-process controls and tests 
to monitor those steps responsible for variability in the process of manufacturing. One of these in-
process control tests is a test for the adequacy of mixing to asssure uniformity and homogeneity. 
“ (a) To assure batch uniformity and integrity of drug products, written procedures shall be 
established and followed that describe the in-process controls, and tests, or examinations to be 
conducted on appropriate samples of in-process materials of each batch. Such control 
procedures shall be established to monitor the output and to validate the performance of those 
manufacturing processes that may be responsible for causing variability in the characteristics of 
in-process material and the drug product. Such control procedures shall include, but are not 
limited to, the following, where appropriate:  
(3) Adequacy of mixing to assure uniformity and homogeneity” (US FDA 2013). 
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Validation may be defined where it is appropriate, but a conclusion cannot be made before validation 
is completed and historical data is analysed. Testing for adequacy of mixing is performed after 
blending and content uniformity is tested after compression into tablets, but testing of adequacy of 
mixing may be warranted after dry mixing for a product that has challenges with passing these tests. 
In this code it is specified that in-process specifications shall be consistent with drug product final 
specifications. The limits applied to the testing of content uniformity after blending might be applied to 
the testing after the dry mixing step. 
Testing after dry mixing is one way to assure adequacy of mixing and hence uniformity and 
homogeneity. The final objective of any powder mixing process is to produce a homogenous blend of 
all powders in the mix, but even determinig mixture composition throughout the dry mixing of powders 
is a difficulty.  
In January 2011, the FDA released its first major process validation guidance in more than twenty 
years (US Department of Health and Human Services 2011). With this guidance came the 
introduction of a lot of new  terms: eg. Design Qualification, Process Development requirements, 
ongoing Process Verification monitoring, Quality by Design, Critical Quality Attribute and the term 
Design Space. Process Validation is now performed across the entire product lifecycle. During the 
first stage, which would be Process Design, companies will need to document the processes 
performed during the development phase of a product. Studies needs to be conducted to identify and 
control sources of variability. This is the stage where process knowledge and understanding needs to 
be built and captured. When the effects of factors on a pharmaceutical process or response are 
unknown, the use of screening designs to estimate the factor effects may be important to be used. 
According to the FDA directive (FDA 2011), manufacturers of pharmaceutical products, should:  
- Understand the sources of variation in the process of manufacturing  a medicine 
- Detect the presence and degree of variation 
- Understand the impact of the variation on the process and ultimitely on product attributes 
- Control the variation in a manner commensurate with the risk it represents to the process and 
product. 
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The unit operation in which two or more materials are interspersed in space with one another is one of 
the oldest and yet one of the least understood unit operations in process engineering (Barbosa-
Cánovas et al., 2005). The mixing of particles in the dry solid state is one of the oldest industrial 
processes known to man (Sudah et al., 2002). In the agricultural, food processing and the 
pharmaceutical industry, mixing operations are used to blend ingredients. The importance of this 
processing step is emphasized in the article by Swaminathan: Solid mixing is an important unit 
operation in the manufacture of pharmaceutical oral solid dosage forms. The importance of producing 
stable mixtures to ensure the uniformity of dosage units with respect to the active ingredient, 
particularly low-dose potent active ingredients, cannot be overstated. Whereas the uniformity of a 
blend does not in itself guarantee uniformity of the drug in a final dosage form, producing a stable 
mixture still remains the first important step in solid dosage form manufacture (Swaminathan & Kildsig 
2002). Dry mixing parameters in a high shear mixer/granulator that are currently used have been 
established through experience, trial and error and in-process testing by means of measuring the 
active drug after blending. Note that it states: assay method after blending and not after dry mixing. 
Data on dry mixing parameters used in high shear mixers/granulators in pharmaceutical companies is 
confidential information; therefore they are not freely available or published.  
Ensuring homogenous mixtures of APIs and excipients and avoiding seggregation (or de-mixing) of 
these mixtures are challenges that pharmaceutical companies face everyday. Despite its importance, 
no definitive and robust approach has been established to quantitatively describe blending dynamic 
(Ngai 2005). Bozzone (2001) suggested that future needs and trends have been identified, one of 
which is to study mixing in equipment with different principles such as high shear mixing. He 
recommended that when blending is shown to be a critical process step, an adequate pilot study of 
the causative factors during process optimisation should be ensured. If  a blend fails the assay test, it 
is important to go back and ensure that the initial dry mixing step was adequate for mixing the 
powders. Previous investigations on mixing of cohesive powders, in general, and pharmaceutical 
materials, in particular, have been limited (Sudah et al., 2002).  
The pharmaceutical company where the Master’s project was performed has had questions from 
MHRA (Medicines and Healthcare products Regulatory Agency) auditors from the United Kingdom, 
asking how they established the parameters for dry mixing of the powders in the high shear 
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mixer/granulator. The question posed were about how it is known that the mixing at the dry mixing 
stage is adequate if not tested? The FDA also wants experiments performed by companies to be 
documented. They require manufacturers to use Design of Experiments to try and establish where 
variability in the process lies. Plackett-Burman is one example of Design of Experiments that can be 
used in the pharmaceutical industry. Quality by Design level knowledge of the critical control 
parameters for key functional performance of a dosage form prior to routine manufacture and 
subsequent validation is becoming more important in the pharmaceutical industry. 
The predicted outcome of this study is to assess the impact of blades speeds and mixing time on 
mixtures of three different ratios of two powders with different densities and particle sizes. This study 
will either discover new optimal parameters or confirm current parameters used on this equipment. It 
will be valuable for the pharmaceutical company in that substantial evidence will be available 
(together with current available data) for optimal dry mixing parameters. This could provide answers 
to possible questions during future audits by regulatory bodies. Proven parameters, based on 
thorough research, can also improve consistency and improve product quality and provide confidence 
to the company that the data they provide to the auditors would be acceptable. Since there has been 
very little published research on dry mixing parameters together with the requirements of the new 
validation guidelines as well as a question posed during an audit, research on dry mixing parameters 
is necessary and hence this research intends to establish optimal mixing parameters by using 
Experimental Design.  
 
1.2 Statement of problem 
The pharmaceutical manufacturer at which these studies were carried out have purchased a 
granulator (Saral Engineering, India) which they use for mixing of powders and for wet granulation 
during the development phase of products. The high shear mixer has an impeller and chopper blades 
which can be set to achieve effective mixing of pharmaceutical powders. In order to carry out the 
mixing process, one needs to determine the ideal settings to mix a typical sample of powder mix 
effectively. Design of experiments could be used to assist. 
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Specific products might fail assay testing after the blending step, in which case it is important to 
ensure that the dry mixing parameters were adequate to ensure adequacy of mixing.  
As mentioned earlier: Bozzone (2001), Ngai (2005) and Sudah et al. (2002) investigated blending in 
blenders. The data generated from these studies is for mixing in blenders and not high shear 
mixers/granulators. 
 
1.3 Aim of the study 
The aim of the study is to determine the optimal settings (speed of impeller and chopper mixing 
blades and mixing times) for dry mixing of typical pharmaceutical powders during the manufacture of 
a product in a high shear mixer/granulator. Three different ratios of two powders (enalapril maleate 
and lactose monohydrate) of different densities and particle sizes will be used. One of the powders’ 
content is quantifiable. 
 
1.4 Objectives 
The study objectives are: 
• To determine how well the mixer mixes three different ratios of two powders with different 
densities and particle sizes at three different impeller blade and chopper blade speeds and for 
three different time periods.  
• To determine the optimal parameters for dry mixing using fractional factorial design.  
 
1.5 Overview of the research 
Chapter 1 briefly describes the background to the research as well as states the aim and objectives. 
This chapter summarizes blending and mixing and explains the need for experimentation on dry 
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mixing parameters in a wet granulation process. The statistical method used in this project is a 
Plackett-Burman design.  
Chapter 2 is a brief outline of the research that has been done on dry mixing and the parameters and 
describes the important theoretical considerations. The research performed using this statistical 
method in the pharmaceutical industry is discussed. This chapter describes the experiments to be 
done in this project.  
Chapter 3 covers the methodology of the research. This chapter elucidates the materials used and 
methods applied in this study.  
Chapter 4 outlines the results, and the discussion thereof follows in chapter 5.  
The recommendations are contained in chapter 5.  
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2. LITERATURE REVIEW 
2.1 Mixing of Pharmaceutical powders 
Although scarce, work focusing on the mixing of pharmaceutical formulations dates back to 1962, 
when Kaufman mixed penicillin G and dihydro-streptomycin sulfate in a double cone and V tumbling 
blenders at various fill levels. One of his observations was that active concentration did not affect the 
homogeneity of a mixture. The statistics were based on 10 samples per experiment obtained using 
thief samplers (Kaufman 1962).  
Ngai (2005) explains that there are many factors influencing mixing. These include: fundamental 
parameters intrinsic to the powder particles, such as size, geometry, moisture content and 
chargeability. These intrinsic fundamental parameters have an influence on the primary effects of the 
powders, including physical interlocking, liquid bridging and tribo-electrostatic interactions. These 
primary effects will ultimately have an effect on secondary effects such as cohesive and frictional 
forces between particles. These secondary effects together with the operating parameters then 
determines the blending kinetics, which includes particle motion, aggregation, deformation and 
breakup (Ngai 2005). Apart from the properties already mentioned, surface properties, flow 
characteristics, friability, moisture content, and tendency to cluster or agglomerate, may influence the 
tendency to seggregate. The closer the ingredients are in size, shape, and density, the easier the 
mixing operation and the greater the intimacy of the final mix (Barbosa-Cánovas et al., 2005).  
The operating parameters include three factors: environmental factors such as humidity and 
temperature; mechanical factors including blend geometry, blender size and blender material as well 
as system factors including initial powder fill volume and blender rotation rate (which in this project 
relates to mixer blade speeds) (Ngai 2005). For this experiment humidity, temperature, mixer 
geometry, mixer size, mixer material and fill volume will stay constant. The choice of an appropriate 
mixer along with mixing time is important (Harnby 1967). The same mixer will be used for all the 
experiments. Venables and Wells (2001) confirm the above when stating that particle size, particle 
shape, particle density, particle charge, choice of mixer, mixing time  and drug concentration are 
factors affecting blend uniformity. Barbosa-Cánovas et al. (2005) state that powder blending is mainly 
affected by the mixing time, the design of the mixer (including size, shape, paddle geometry, and 
9 
 
rotational speed) and type of powders being mixed. Drug content variation increases with decreasing 
drug content, and this is therefore important when attempting to achieve blend uniformity with a low-
dose drug (Egermann & Pichler 1988 cited in Venables & Wells 2001). Drug:excipient ratio has no 
effect (Venables & Wells 2001). Although the small concentration of active ingredient in a low-dose 
formulation (<1% w/w) has always been assumed to be the reason for poor content uniformity, not 
much experimental evidence is available (Venables & Wells 2001). A study performed by Greaves et 
al. concluded that content uniformity is improved when the active ingredient is dispersed in an 
aqueous system. This was then used as the granulating agent in the wet granulation process 
(Greaves et al., 1995). Using this approach would hence exclude the testing of the dry mix, as was 
performed in this project. A small amount of cohesive active could be pre-blended with a much larger 
amount of free-flowing excipient. This could also aid with content uniformity (Alexander et al., 2004). 
The challenge of content uniformity when there is a small concentration of active in the mix is one that 
could be overcome. Alexander and Muzzio (2006) that discuss dry blending and mixing in blenders 
confirm the variable parameters in mixing  when discussing scaling up for dry Blending and Mixing: by 
stating that the questions that arise include: What rotation rate should be used?; How long should the 
blender be operated?. They also confirm that there is no generally accepted method for approaching 
answers to these questions; and therefore ad hoc approaches tend to be the rule rather than the 
exception.   
Three mechanisms have been recognised in solids mixing: convection, diffusion and shear (Barbosa-
Cánovas et al., 2005). In any particular process one or more of these three basic mechanisms may be 
responsible for the course of the operation. High shear mixers mostly have shear mixing.  
Shear mixing is induced by the momentum exchange of powder particles having different velocities 
(differential velocity distribution). Shear mixing is developed by the formation of slipping planes in the 
bulk material; the originally coherent particle groups are gradually broken along these planes. The 
velocity distribution develops around the agitating impeller and the vessel walls due to compression 
and extension of bulk powders (Barbosa-Cánovas et al., 2005). It is important to note that the 
operating principle in blenders differ to those in high shear mixers. The literature on studies performed 
in blenders are mostly in blenders that uses diffusion mixing. Due to the difference in operating 
principles, the results from these studies cannot be applied directly to high shear mixers/ granulators. 
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In a high shear mixer, blades  are used to mechanically dilate and shear the powders. Hickey and 
Ganderton (2001) state in their book on Pharmaceutical Process Engineering that “since the shearing 
of particles in a bed to achieve a uniform mix or blend is a statistical process, it must be monitored for 
efficiency. Sample thieves are employed to probe the powder bed, with minimal disturbance, and 
draw samples for analysis. These samples are then analyzed for the relevant dimension for mixing, 
eg. drug content. Statistical mixing parameters have been derived based on mean and standard 
deviation of samples taken from various locations in a blend at various times during the processing”.  
In any operation mixing and de-mixing may occur concurrently, and the intimacy of the resulting mix 
depends on the predominance of the former mechanism over the latter. Once the mixing and de-
mixing mechanism reach a state of equilibrium, the condition of the final mix is determined and further 
mixing will not produce a better result (Barbosa-Cánovas et al., 2005). A chopper blade is used to 
create the necessary shear forces to break up agglomerates of cohesive materials.  
A study performed by Samual Ngai (2005) on blenders showed that the time required to reach a 
homogenous mixture increased with blender fill volume and decreased with blender rotation rate 
(rpm). With respect to the effect of operating parameters on blending kinetics, the simulations showed 
that the homogenous mix increases as fill volume increased, rpm decreased, or when Microcrystalline 
Cellulose as opposed to lactose was chosen as an excipient. The experiments were performed in lab 
blenders. Even though dry mixing and blending is supposed to have the same function, to create an 
evenness of the mixture, blenders operate by convection and diffusion mixing and it is hence very 
difficult to apply conclusions made from studies performed on such equipment to the mixing in high 
shear mixers/granulators. A guideline for mixing was drawn up by Venables and Wells (2001) and 
four of the factors mentioned include: Drug concentration (low drug concentration can lead to poor 
content uniformity), Mixer choice (use segregating mixers for friable or unisize particles and use 
nonsegregating mixers for materials prone to segregation), Mixing time (must be optimized for each 
mix to minimize segregation) and Sampling (use common sense to determine a suitable sample size, 
sample the whole stream for many short periods of time and sample while the powder is in motion). 
From the study performed by Sudah et al. in blenders (2002), it was also concluded that the 
concentration of the active component did not affect the outcome of the mixing process, formulations 
at 3 % and 30 % KCl generated nearly identical results. Extensive work has been performed for active 
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distribution in blending systems, but data on mixing/blending in a high shear mixer system is minimal. 
Since it is easier to perform tests on lab-scale equipment that matches production, the burden is on 
development organisations to obtain appropriate high shear mixers based on proper scaling down of 
those that will be in production.  
Vojnovic et al. (1992) state that “wet granulation is a technological process of size enlargement used 
in the pharmaceutical industry to prepare powdered materials for capsules and tablets. Despite the 
extensive use of the technique there is a lack of systematic research concerning the relationship 
between process variables and granule properties on the small scale high shear mixers”. Dry mixing 
is the first step in wet granulation. 
Powder mixing is a complex process. Even today, there is no simple list of rules that can be followed 
to create a perfect mix; however, there are guidelines that can be followed to minimize segregation 
and agglomeration (as mentioned previously from research performed by Venables & Wells). By 
continually updating mixing methods used in the pharmaceutical industry, these problems can be 
removed, and powder mixing can be made a much more efficient process (Venables  
& Wells 2001). Venables & Wells (2001) state that their article on powder mixing is part of a much 
larger subject for which far more work is needed. Not enough time is taken by most pharmaceutical 
companies to raise awareness of the bias and other errors when mixing and sampling, its importance 
is underestimated (Venables & Wells 2001). 
With the new Validation guideline from FDA in 2011 it has been made clear that more statistics will 
need to be used to prove that the process is capable of consistently delivering quality products. In the 
introduction of this guideline it states: “The guidance aligns process validation activities with a product 
lifecycle concept and with existing FDA guidance, including the FDA/International Conference on 
Harmonisation (ICH) guidances for industry, Q8(R2) Pharmaceutical Development, Q9 Quality Risk 
Management, and Q10 Pharmaceutical Quality Systems. Although this guidance does not repeat the 
concepts and principles explained in those guidances, FDA encourages the use of modern 
pharmaceutical development concept, quality risk management, and quality systems at all stages of 
the manufacturing process lifecycle” (FDA, 2011). In the International Conference on Harmonisation 
Harmonised Tripartite Guideline (Q8(R2) Pharmaceutical Development)  it also specifies that critical 
process parameters are generally identified through an assessment of the extent to which their 
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variation can have an impact on the quality of the drug product (ICH 2009). This project can serve as 
an example to industry of how to incorporate the guidelines and Design of Experiments. One of the 
recent developments in the validation of pharmaceuticals is risk assessment. In figure 1, a fishbone 
diagram is used to identify the potential variables which can have an impact on the desired quality 
attribute, which in this project is the homogeneity of the mixture.             
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Figure 2.1: Fishbone diagram for risk analysis 
Four potential variables have been chosen from the knowledge gained from literature review and from 
probability, severity and detectability of the variables based on prior knowledge which can have an 
impact on the quality attribute. Experimental data will be created in this project that can be used to 
make decisions in future. Design of experiments is used to evaluate the impact of the higher ranked 
variables, to gain greater understanding of the process and to develop a proper control strategy to 
remain within the design space established for a certain product. This is data that can be shown to 
auditors and can form part of the initial development process. 
 
2.2 Statistical optimisation 
Experimentation is expensive in terms of time, work force, and resources. It is therefore practical to 
ask whether experimentation can be made more efficient, and hence reducing expenditure of time 
and money (Armstrong 2006). A study on wet granulation in a small scale high shear mixer used 
Fundamental parameters  
intrinsic to the powder 
 
Environmental factors Active and Inactive 
Pharmaceutical Ingredients  Mixer equipment (high shear mixer) Operating parameters 
Secondary effects Primary effects 
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experimental design. There were three process variables (moisture level, impeller blade speed and 
granulation time). The conclusion drawn from this study was that centered composite design may be 
used in the pharmaceutical process of granulation to plan the experimental design and to find the 
main effects and interactions of the process variables on the physical properties of the granulate. The 
method is also recommended to optimize the process variable in a laboratory scale high shear mixer 
(Vojnovic et al., 1992). Another study assessing the influence of chopper blade and mixer/impeller 
blade speeds and microwave power level during the high-shear granulation process on final granule 
characteristics successfully used central composite factorial design (Kiekens et al., 1999). 
Operating parameters are often chosen according to previous experience, by expert knowledge or by 
systematic screening. This project concentrates on statistical experimental design-based optimization. 
Design of experiments can be used to optimize an operating process. Design of experiments is used 
in this project. Plackett-Burman design can be used to establish out of many variables that might 
affect the outcome of an experiment, which one will prove the most important and hence justify more 
extensive study. Venables & Wells (2001) conclude in their article that: “When analysing the variance 
of a mix, many methods are available. Indices still remain popular today, as does the Poisson 
distribution, but both methods have their limits, and the ANOVA technique investigated by Rollins et 
al. may provide a useful alternative, especially for segregation determination”. Plackett-Burman 
design was chosen for this project as it is a fractional factorial design. A fractional design requires a 
limited number of experiments. This is desirable for industry as experiments takes time and is costly. 
The type of design is hence a factorial design type that can be used again in this industry. It is 
anticipated that the type of design will provide the information that is required from the experiments- to 
determine optimal parameters.  
Singh (2011) states in his article that formulation development of the oral drug delivery systems 
cannot be adequately accomplished using the traditional ‘trial and error’ approaches of one variable at 
a time. Ngai (2005) also confirms this by stating that due to a lack of fundamental understanding in 
powder mixing makes trial and error the best practice in the industry. This calls for the adoption of 
rational, systematized, efficient, and cost efficient strategies using ‘design of experiments’. He also 
says that the recent regulatory guidelines issued by the key federal agencies to practice ‘quality by 
design’ paradigms have coerced researchers in industrial milieu, in particular, to use experimental 
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designs during the product development. This would include design of experiments (DoE), of which 
Plackett-Burman would be an example of a DoE that can be used for screening. Design of 
experiments is also a tool that can be used during risk evaluation. A design space could be created 
for a specific product based on DoE. This can aid in risk decision making. This use of experimentation 
is also mentioned in the article by Charoo & Ali: “The objective of ICH Q8, Q9 and Q10 documents is 
the application of systemic and science based approach to formulation development for building 
quality into product. There is always some uncertainty in new product development. Good risk 
management practice is essential for success of new product development in decreasing this 
uncertainty” (Charoo & Ali 2013). 
Currently no mathematical techniques exist to predict blending behaviour of granular components 
without prior experimental work. Therefore, blending studies start with a small-scale, try-it-and-see 
approach (Alexander & Muzzio 2006). Actual knowledge in mixing is a combination of “know-how” 
and science, in which “know-how” is predominant and only a few individuals and specialized 
companies around the world have a thorough knowledge of this matter (Barbosa-Cánovas et al., 
2005). Most of the powder mixing science in academia and industry is based on emperical 
approaches or experience based correlations, allowing only limited understanding of the blending 
behaviours of pharmaceutical powders (Crowder & Hickey 2000 cited in Ngai 2005). Ngai states that 
this lack of fundamental understanding in powder mixing makes trial-and-error the best practice in 
industry. Blend samples analysis should be conducted on development batches by extensive testing 
in the mixer. Advances in quantitative measures of dry solids mixing help to control mixer 
performance. In actual practice, however, a mixer is tested by the properties in the mixed material that 
it produces. Developments in mathematical modeling of mixing processes are scarce and established 
procedures for process design and scale-up are lacking (Barbosa-Cánovas et al., 2005).  
Application of statistics has broadened far beyond its origin to various areas of research and one 
among them is the design of experiments (Jacquez 1998). “Design of experiments gathers the 
maximum amount of information in the lowest number of analyses. In order to optimize a process and 
maintain repeatability, screening designs are performed” (Vanaja & Shobha Rani 2007). Vanaja and 
Shobha Rani concluded that screening designs used in early stages of research and development 
helps the researcher to identify the significant factors for a large-scale simulation with a relatively 
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small number of runs. As Plackett-Burman design is a multiple of four, it generates the most 
information for the least amount of work involving the fewest runs. This type of design identifies the 
factors to be examined more intensely allowing intelligent decision making for future research and 
development. Applying DoE throughout a pharmaceutical process is the key to quality by design- it 
maximizes the information content of a small number of experiments.  The Plackett-Burman design 
was developed by R.L. Plackett and J.P. Burman in 1946 and was designed to improve the quality 
control process that could be used to study the effects of design parameters on the system state so 
that intelligent decisions can be made. 
“Design of experiments (DoE) studies can help develop the process knowledge by revealing 
relationships, including multivariate interaction, between the variable inputs (e.g., component 
characteristics or process parameters) and the resulting outputs (e.g., in-process material, 
intermediates, or the final product). Risk analysis tools can be used to screen potential variables for 
DoE studies to minimize the total number of experiments conducted while maximizing knowledge 
gained. The results of DoE studies can provide justification for establishing ranges of incoming 
component quality, equipment, parameters, and in-process material quality attributes” (FDA 2011: 8). 
“It is essential that activities and studies resulting in process understanding be documented. 
Documentation should reflect the basis for decisions made about the process. For example, 
manufacturers should document the variables studied for a unit operation and the rationale for those 
variables identified as significant” (FDA 2011: 9). 
Design of Experiments is not a new concept. Over the years Plackett-Burman design has been 
applied to experiments performed in the pharmaceutical industry. Table 2.1 has examples of 
experiments where the Plackett-Burman design was successfully used as an experimental design 
screening method. 
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Table 2.1: Studies performed on pharmaceuticals using Plackett-Burman design of experiments 
Article/dissertation title Journal/Resource Content 
Effective parameters in 
determining cross-linked dextran 
microsphere characteristics: 
screening by Plackett-Burman 
design of experiments. 
Kenari, HS., Alinejad, Z., Imani, M., 
Nodehi, A. 2013. Journal of 
Microencapsulation. Posted online 
27 March 2013. 
Screen the effective parameters in preparing 
cross-linked dextran microspheres to make them 
controllable for obtaining microspheres with 
tunable properties. A Plackett-Burman design of 
experiments was employed as screening 
methodology to investigate the effects of the 
kinetics and process parameters, i.e. the mixing 
speed and emulsification time on the resulting 
microsphere characteristics. Increasing dextran 
concentration in the aqueous phase leads to a 
significant increase in the mean particle size and 
decrement on water uptake capacity of the 
resulting microspheres, respectively. 
“Vitamin E” fortified parenteral 
lipid emulsions: Plackett-Burman 
screening of primary process and 
composition parameters.  
Alayoubi, A., Nazzal, M., Sylvester, 
PW., Nazzal, A. 2013. Drug 
Development and Industrial 
Pharmacy, 39 (2): 363-373. 
The objective of this study was to screen the 
effect of eight formulations and process 
parameters on the physical attributes and stability 
of “Vitamin E”-rich parenteral lipid emulsions. 
Screening was performed using a 12-run, 8-
factor, 2-level Plackett-Burman design. The 
identification of parameters by a well-constructed 
design demonstrated the utility of screening 
studies in the “Quality by Design” approach to 
pharmaceutical product development. 
Preparation and Optimization of 
Mouth/Orally Dissolving Tablets 
Using Combination of Glycine, 
Carboxymethyl Cellulose and 
Sodium Alginate: A Comparison 
with Superdisintegrants. 
Vora, N and Rana, V. 2008. 
Pharmaceutical Development and 
Technology, 13 (3): 233-243. 
The purpose of the study was to prepare 
metoclopramide HCl mouth/orally dissolving 
tablets (MDTs) using glycine, carboxy methyl 
cellulose and sodium alginate with sufficient 
mechanical integrity and disintegration time 
comparable to superdisintegrants. Application of 
Plackett-Burman design revealed that 
concentration of glycine, concentration of carboxy 
methyl cellulose and tablet crushing strength 
were found to actively influence the dependent 
variables (disintegration time in oral cavity, 
wetting time, porosity and water absorption ratio). 
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Article/dissertation title Journal/Resource Content 
Controlled Release 
Multiparticulate Beads Coated 
with Starch Acetate: Material 
Characterization, and 
Identification of Critical 
Formulation and Process 
Variables. 
Nutan, MTH., Vaithiyalingam, SR., 
Khan, MA. 2007. Pharmaceutical 
Development and Technology, 12 
(3): 307-320. 
The objectives of the investigation were to 
prepare and characterize starch acetate with high 
degree of substitution and to study its prospect as 
film-forming agent in a controlled-release 
multiparticulate drug delivery system. As part of 
the development process by quality by design, 
the objectives also included identification of 
critical formulation and process variables that 
affect the release of a drug. A seven-factor, 
twelve run Plackett-Burman screening design 
was used. The main effects on drug release after 
12 hours decreased in the following order: 
coating weight gain, plasticizer concentration, 
post drying temperature, SA concentration, inlet 
temperature, post drying time, and atomizing 
pressure. 
Robustness Testing of a Tablet 
Formulation Using Multivariate 
Design. 
Gabrielsson, J., Sjöström, M., 
Lindberg, NO., Pihl, AC., Lundstedt, 
T. 2006. Drug Development and 
Industrial Pharmacy, 32 (3): 297-
307. 
45 experiments were carried out to evaluate the 
robustness of two similar tablet formulations-a 
product of two strengths-with respect to normal 
batch-to-batch variation of the excipients and the 
active pharmaceutical ingredient. Because of the 
differing amounts of active pharmaceutical 
ingredients, the two formulations also differ in the 
amounts of two of the diluents and one of the 
binders. A Plackett-Burman design was applied 
to the principle properties. Both formulations were 
found to be robust under controlled conditions. 
Drug-Excipient Compatibility 
Testing Using a High-Throughput 
Approach and Statistical Design. 
Wyttenbach, N., Birringer, C., 
Alsenz, J., Kuentz, M. 2005. 
Pharmaceutical Development and 
Technology, 10 (4): 499-505. 
The aim of the research was to develop a 
miniaturized high throughput drug-excipient 
compatibility test. Experiments were planned and 
evaluated using statistical experimental design. 
To address all factors in this research a 
considerable number of tests are required. To 
reduce the number of experiments, fractional 
designs have been used. Plackett-Burman 
design was used to study the effect of various 
excipients, as well as humidity and temperature 
on pyridoxal hydrochloride degradation. In 
conclusion, the developed technique enables fast 
drug-excipient compatibility testing and 
identification of interactions. 
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Article/dissertation title Journal/Resource Content 
A Dual Controlled Gastrointestinal 
Therapeutic System of Salmon 
Calcitonin II.  Screening of 
Process and Formulation 
Variables. 
Shah, RB., Nutan, M.,,Reddy, IK., 
Khan, MA. 2004. Clinical Research 
and Regulatory Affairs, 21(3-4): 231-
238. 
An important aspect of the “Desired State” of the 
manufacturability as defined by the International 
Committee of Harmonization is the mechanistic 
understanding and predictability of dosage forms 
at the laboratory scale. The accomplishment of 
that aspect is often preceded by a formulation 
knowledge and previous history of the project or 
by screening of the variables to identify the critical 
ones. A seven-factor-12-run Plackett-Burman 
screening technique was employed to evaluate 
the effects of orifice size, coating level, amounts 
of sodium chloride, Polyox ® N10 and N80 and 
Carbopol ® 934P and 974P on drug release. 
Factors showing maximum influence on drug 
release were amounts of Carbopol ® 934P and 
Polyox ® N10 in the drug layer, orifice size and 
coating level showing negative effects.  
Using Experimental Design to 
Optimize the Process Parameters 
in Fluidized Bed Granulation. 
Rambali, B., Baert, L., Thoné, D., 
Massart, DL. 2001. Drug 
Development and Industrial 
Pharmacy, 27(1): 47-55. 
In this study many parameters were screened for 
a small-scale granulation process for their effect 
on the yield of granules between 75 and 500 µm 
and the geometrical granule mean size. First a 
Plackett-Burman design was applied to screen 
the inlet air temperature, the inlet flow rate, the 
spray rate, the nozzle air pressure, the nozzle 
spray diameter, and the nozzle position. The 
Plackett-Burman design showed that the key 
process parameters were the inlet flow rate and 
the spray rate and probably also the inlet 
temperature. 
The role of Intra- and 
Extragranular Microcrystalline 
Cellulose in Tablet Dissolution. 
Li, JZ., Rekhi, GS., Augsburger, LL., 
Shangraw, RF. 1996. 
Pharmaceutical Development and 
Technology, 1 (4): 343-355. 
The objective of this study was to examine the 
influence of intra- and extragranular 
microcrystalline cellulose (MCC) on drug 
dissolution from tablets made by high-shear 
granulation. A Plackett-Burman screening 
design and 23 factorial design were employed to 
study how drug type, MCC (intra- or extra-), filler 
type (lactose or dicalcium phosphate), 
disintegrant type (sodium starch glycolate or 
croscarmellose sodium) and level, proportion of 
magnesium stearate, and impeller speed affect 
tablet hardness, disintegration time, and 
dissolution. It is concluded that the appropriate 
distribution of MCC between and within granules 
may optimize both dissolution and compactibility 
without changing overall tablet composition. 
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Article/dissertation title Journal/Resource Content 
Development of Matrix Controlled 
Release by Extrusion-
Spheronization Technology Using 
Statistical Screening Design. 
Goskonda, SR., Hileman, GA., 
Upadrashta, SM. 1994. Drug 
Development and Industrial 
Pharmacy, 20 (3): 279-292.  
The objective of the study was to develop beads 
with inherent modified release characteristics 
requiring no subsequent controlled release 
coating. A Plackett-Burman screening design 
was employed to isolate critical variables 
influencing the bead characteristics and drug 
release. Beads were successfully manufactured 
according to the screening design and exhibited 
different dissolution characteristics. Polymer type 
(Eudragit RS 30 D over Aquacoat ECD-30), 
polymer concentration and acid concentration 
significantly retarded drug release. However, 
increasing acid concentration increased bead 
friability. In addition to drug concentration, higher 
polymer concentration, appropriate acid selection 
and longer residence times afforded maximum 
capsule fill weights and increased bead density. 
A Factorial Approach to High 
Dose Product Development by an 
Extrusion/Spheronization 
Process. 
Hileman, GA., Goskonda, SR., 
Spalitto, AJ., Upadrashta, SM. 1993. 
Drug Development and Industrial 
Pharmacy, 19 (4): 483-491. 
Extrusion/spheronization technology has been 
used for preparing high drug-loaded pellets. A 
Plackett-Burman screening design was 
employed to investigate product and process 
parameters affecting final pellet drug content, 
density and roundness. Microcrystalline Cellulose 
type and concentration, water concentration, 
spheronizer speed and residence time and 
extruder screen size were found to be statistically 
significant in imparting desirable attributes to the 
final product. Wet mixing time, extruder feed rate 
and extrusion rate did not significantly affect the 
pellet properties. 
Quantitation of the Amount and 
Uniformity of Aqueous Film 
Coating Applied to Tablets in a 
24” Accela-Cota. 
Skultety, PF., Rivera, D., Dunleavy, 
J., Lin, CT. 1988.  Drug 
Development and Industrial 
Pharmacy, 14 (5): 617-631. 
A simple technique was developed to quantify the 
amount of coating solution applied to individual 
tablets. A Plackett-Burman experimental design 
was used to determine the processing 
parameters in a 24” Accela-Cota which can 
influence the homogeneity of film coating applied 
to tablets. The processing parameters that were 
found to affect the film coating were: coating 
drum speed; amount of aqueous film coating 
liquid applied; and the spray pattern. The starting 
location of the tablets in the tablet bed did not 
affect the amount of coating applied or the 
variability of the coating. Different size and shape 
tablets were found to behave similarly as to what 
processing parameters were significant in the 
amount of coating applied and the variability 
between tablets.  
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Article/dissertation title Journal/Resource Content 
Evaluation of the Loss of 
Propylene Glycol During Aqueous 
Film Coating. 
Skultety, PF., Sims, SM. 1987. Drug 
Development and Industrial 
Pharmacy, 13 (12): 2209-2219. 
A Plackett-Burman study was used to determine 
the coating factors which can affect the loss of 
propylene glycol, a common water soluble 
plasticizer used on aqueous film coating, during 
the film coating process. Analysis of the data 
shows that the amount of the propylene glycol in 
the film was 81 to 96 % less than the theoretical 
value when considering the amount of the 
propylene glycol in the aqueous film coating 
liquid. The loss of propylene glycol was 
independent of the variables studied. The loss of 
propylene glycol was also shown to occur in the 
Accela-Cota during the coating of tablets. 
Buccoadhesive films for once-a-
day administration of rivastigmine: 
systematic formulation 
development and pharmacokinetic 
evaluation. 
Kapil, R., Dhawan, S., Beg, S., 
Singh, B.  2013. Drug Development 
and Industrial Pharmacy, 39 (3): 
466-480. 
A Plackett-Burman Design was employed for 
screening of significant formulation and process 
variables involved in the development of 
buccoadhesive films. 
Implementation of the design helped in identifying 
the most significant factors for further detailed 
investigation with minimum experimentation, thus 
saving considerable time, effort and materials. 
Formulation of an anti-
tuberculosis drug delivery system. 
Du Toit, LC. 2007. Masters 
dissertation, vi, 266. 
Statistical experimental design (Plackett-
Burman), implementing response-surface 
methodology was pivotally instituted on the 
multiparticulate forms for the identification of 
critical formulation and processing variables for 
the development of the optimum enterosoluble 
and reconstitutable multiparticulate systems for 
delivery to the patient as the preferred 
multiparticulate two-drug FDC. 
 
2.3 Sampling techniques 
In establishing guidance for good mixing parameters, one needs to keep in mind that it is also 
dependent on reliable, accurate, analytical data for which sampling is an integral and pivotal issue 
(Venables & Wells 2001).  
Once samples have been collected from the bowl of the granulator, by sampling methods, the mean 
value and sample variance are determined and then often used in a mixing index. Many mixing 
indices are available; however, there is no general mixing index, so choice of index is left to the 
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individual investigator (Poux et al., 1991 cited in Alexander & Muzzio 2005). Once a measure of 
mixedness has been defined, it is then tracked over time until suitable homogeneity is achieved. 
Ideally, this minimum level of variance would stay relatively constant over a sufficiently long time. This 
procedure is simple in concept, but many problems have been associated with characterisation of 
granular mixtures (Muzzio et al., 1997 cited in Alexander & Muzzio 2005). One dangerous assumption 
is that a small number of samples can sufficiently characterize variability throughout the blend. 
Furthermore, sample size can have a large impact on apparent variability. Samples that are too small 
can show exaggerated variation, while too large a sample can blur concentration gradients. A 
sufficient number of samples should be taken representing a large cross-section of the blender 
volume. The sample size for pharmaceutical products is ideally of the scale of the unit dose and in the 
case of small unit doses the goal should be to sample at a size within the resolution of the sample 
thief (Hickey & Ganderton 2001). 
Sampling thief probes remain the most commmonly employed instrument for sampling powders for 
data gathering. (Muzzio et al., 1999). These instruments have however been demonstrated to 
sometimes induce large sampling errors coming from poor flow into the thief cavity or sample 
contamination (carryover from other zones of the mixer) during thief insertion (Muzzio et al., 1997 
cited in Alexander & Muzzio 2005).  
An end-sampling thief was used successfully to collect all samples in the study conducted on 
blenders by Sudah et al. (2002). The sampler has hollow tubes with one end filed to a sharp edge, 
which minimise bed disturbance when thrust into the mixture. 
Acceptance criteria for blend assay used during Bozzone’s (2001) research study: 10 samples from 
powder blends, and individual assay % RSD < 5.0 %. Demonstration of mix and content uniformity for 
exhibit and/or validation batches: from the blend, sample at least 10 locations, with at least 3 
replicates from each location. Assay 1 per location. Blend sample criteria: RSD < 5.0 % and all 
individuals are within 10 % (absolute) of the mean of the results. Absolute as used to define the 
acceptable range (+ 10 %) in which individual blend sample values must fall is dependent of the value 
of the mean. For example, if the mean of all blend samples is 95.0 %, the absolute range is 85 – 105 
%. This was for a study performed on blenders. Stratified sampling of blend and dosage units to 
demonstrate adequacy of mix for powder blends has also been suggested (Prescott & Garcia 2001). 
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3. METHODOLOGY 
By using a Fishbone diagram for risk analysis in figure 2.1, the factors that are more likely to have an 
impact on the outcome were assessed. Operating parameters were be the main focus of this project 
and the influence it has on the homogeneity of a mix. Two of the factors that were assessed include 
mixer/impeller blade and chopper blade speeds. The third factor that was assessed in this study 
includes mixing time. Different ratios of two powders were used in these experiments. 
With this project it was established which aspect has the most important impact on the desired quality 
attribute, which is homogeneity of the mixture, through varying four of the parameters (mixing time, 
mixer/impeller blade speed, chopper blade speed, different ratios of two powders). These factors 
were investigated in a design of experiments. 
 
3.1 Materials 
Two raw materials of different density and particle sizes were mixed together: lactose (DMV Fonterra 
Excipients, Germany) and enalapril (Zhejiang, China). Enalapril was chosen as one of the raw 
materials as it can be quantified via assay testing and can therefore indicate the adequacy of the 
mixture. The type of powders were the same for the experiments, however the impact on three 
different ratios of the two powders were assessed. 
 
3.1.1 Logistics 
The experiments were performed in a Research Laboratory at a pharmaceutical company. The 
laboratory testing was performed in the analytical laboratory at the pharmaceutical manufacturing 
company. This is a MCC (Medicines Control Council) approved facility. MCC is the regulatory 
authority in South Africa. Mixing and testing were performed by the researcher.  
The temperature was maintained at 22.5 °C (+ 2.5 °C). 
The relative humidity was maintained at less than 45 %. 
23 
 
3.1.2 Equipment 
A Saral Rapid mixer and wet Granulator (Saral Engineering Company, India) were used. The model 
is: RMG 10 Ltr. (R&D Model). The main impeller blade runs in the horizontal plane and the chopper 
blade runs in the vertical plane. It is a precise machine performing dry mixing and wet granulation in 
the same bowl. The main impeller blade range is 1–205 rpm and the chopper blade range is 0-2880 
rpm (Saral, 2006). The two blades were operated at a low, medium and high speed. The function of 
the mixer blade is to mix and the function of the chopper blade is to break up lumps. Dry mixing time 
suggested by the manufacturer for this machine is 2 – 4 minutes. Working capacity is 4 kg batch size 
(assuming a bulk density of 0.5). Overflow capacity is 10 kg. The equipment has been qualified. This 
equipment is bottom-driven. Figure 3.1 is an illustration of the equipment and figure 3.2 is an 
illustration of the blades. 
 
Figure 3.1: Saral Rapid Mixer and wet granulator R&D model 
 
 
Figure 3.2: Mixer blades of Saral Rapid Mixer and wet granulator R&D model 
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3.1.3 Formulations of powder mixtures for analysis 
Formulations consisted of lactose, which is a diluent/bulking agent and enalapril maleate. The two 
materials need to be evenly distributed throughout the mixture to ensure that the end-product has the 
correct amount of each of the ingredients per tablet as per the label claim. The high shear mixer was 
loaded with the lactose first and then the enalapril on top of the lactose in the middle of the bowl, 
before switching on the mixer.The formulations tested were as per table 3.1. 
Table 3.1: Three formulations with different ratios of two powders used in experiments 
Formulation 0.2 % w/w  
Enalapril ratio 
10.1 % w/w 
Enalapril ratio 
20.0 % w/w  
Enalapril ratio 
Enalapril maleate 0.008 kg 0.404kg 0.800 kg 
Lactose monohydrate 3.992 kg 3.596 kg 3.200 kg 
Total 4.000 kg 4.000 kg 4.000 kg 
 
Lot numbers for batches of raw material used in experiments: 
Lactose: B018216 (used in Batch 1) 
B021515 (used in Batches 2 and 3) 
Enalapril:  X111972 (used in Batch 1) 
B022065 (used in Batches 2 and 3) 
Refer to Certificates of analysis for these batches in Appendix A. 
From the certificates it can be seen that the bulk density and particle size for the materials were as 
listed in table 3.2. 
 
Table 3.2: Particle size and bulk densities for materials used in the experiments 
Lot numbers Particle size Bulk density 
B018216 78-86 % < 31 µm 
98 % < 41 µm 
0.781 g/ml 
B021515 78-86 % < 75 µm 
98 % < 16 µm 
0.836 g/ml 
X111972 90 % < 20 µm - 
B022065 90 % < 20 µm - 
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The lactose is the biggest part of the mixture and therefore the bulk density of the lactose is 
mentioned. The enalapril is a small portion of the mixture and would not have a great impact on the 
bulk density of the mixture. 
 
3.2 Methods 
3.2.1 Statistical Experimental Design 
Design of Experiments was used. The project followed a 24 Plackett-Burman factorial experimental 
design. The designs were developed using the Essential Experimental Design© program EREGRESS 
Version 2.209 (2006-Copyright). The program is freeware and was developed by R.P. Yeater, D.D. 
Steppan and J. Werner. 
In statistics, regression analysis is a collective name for techniques for the modelling and analysis of 
numerical data consisting of values of a dependent variable (also called response variable or 
measurement) and of one or more independent variables (also known as explanatory variables or 
predictors). 
The dependent variable in the regression equation is modelled as a function of the independent 
variables, corresponding parameters (“constants”) and an error term. 
Linear regression was used to determine the extent to which there is a linear relationship between a 
dependent variable and one or more independent variables.  
The following statistics were used:  
- Summary  
- p value 
- R2 = % predicted by model correlation 
- Analysis of variance 
- Critical significance? 
- Response surfaces plots 
- 95 % CI- 5 % chance of error 
- Correlation matrix 
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- Current value- it calculate what the best parameters will be to get the lowest % RSD. The 
optimal parameters can be predicted.  
- Predicted vs actual. 
In experimental designs, a number of cause factors and response variables (dependent variable) are 
selected. The relationship between cause variables and response is established mathematically. The 
optimal response variable can then be obtained by selecting the optimal cause variables.  
The factors tested and thus the four input parameters are listed in table 3.3. The output parameter is  
% Relative Standard Deviation (% RSD) for assay tested from 7 samples taken from predetermined 
points in the bowl after the mixing time for the specific experiment was completed. A lower % RSD 
would indicate a more homogenous mix. A high % RSD would indicate that the two powders are not 
yet well distributed throughout the mixture. 
 
Table 3.3: High, medium and low level settings for high speed mixer/granulator in the Plackett- 
Burman Screening Design 
Factor Factor Level Unit Outcome 
Low (-1) Medium (0) High (+1) 
Enalapril 
concentration 
0.20 10.10 20.00 % w/w Assayed seven 
samples from each 
experiment. 
Determined % 
RSD (Relative 
Standard 
Deviation) for each 
set of seven 
samples 
Speed of blades 
           Main Impeller 
 
50 
 
125 
 
200 
 
rpm 
           Chopper  1000 1900 2800 rpm 
Mixing time 0.5 2.0 3.5 minutes 
 
Table 3.4 lists the experimental design, detailing the levels of the formulations to be tested.  
Each experiment was performed on three batches. 
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Table 3.4: 24 two-level Plackett-Burman Design table showing experimental runs 
Plackett-Burman Design, Resolution 3 
4 Factors 
12 model runs and 
 2 Center points  
(experiments 4 & 6 and 5 & 12) 
 Linear Model with 5 terms 
 Equition:  
Response = b0 + b1*enalapril, % w/w + b2*Impeller, rpm + b3*Chopper, rpm + b4*Time, minutes 
 
Exp # 
Enalapril ratio, 
%w/w 
Impeller speed, 
rpm 
Chopper speed, 
rpm 
Time,  
minutes 
1 0.20 50 1000 0.5 
2 0.20 200 2800 3.5 
3 0.20 200 1000 0.5 
4 10.10 125 1900 2.0 
5 20.00 200 1000 3.5 
6 10.10 125 1900 2.0 
7 0.20 200 2800 0.5 
8 20.00 50 2800 3.5 
9 0.20 50 2800 3.5 
10 0.20 50 1000 3.5 
11 20.00 200 2800 0.5 
12 20.00 200 1000 3.5 
13 20.00 50 1000 0.5 
14 20.00 50 2800 0.5 
 
As yet, no reliable techniques for on-line measuring of composition have been developed; hence, 
powder mixtures are usually quantified by removing samples from the mixture. To determine blending 
behaviour over time, the blender is stopped at fixed intervals for sampling; the process of interrupting 
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the blend cycle and repeated sampling may change the state of the blend (Alexander & Muzzio 2006). 
For this study, the mixing was not interrupted for sampling. The powders were mixed for the full time 
and was then sampled. 
 
3.2.2 Sampling of powder mixtures that was analysed 
For each experiment seven samples were taken from seven different points in the bowl. It was taken 
at the top and bottom of the bowl at three points in the bowl and one sample was taken from a point in 
the top middle of the bowl. Figure 3.3 illustrates the sampling points in the bowl. Samples were taken 
in duplicate, but only one sample per location was tested. The seven samples were sufficient to 
represent a large cross-section of the entire bowl surface.  
Sample size was  + 400 mg. 
For blend uniformity, sample size must be at most 3 unit dosages. This criteria originated from the 
U.S. vs. Barr Laboratories court case (United States of America, Plaintiff, vs. Barr Laboratories, Inc. et 
al., Defendants. 1993) that took place in New Jersey in 1993. “The proper blend sample size for 
content uniformity testing is three times the run weight of the finished product” (Buckley & Associates 
2004). 
The sample size is approximately 3 times the weight of a tablet (150 mg x 3 = 450 mg). 
Enalapril tablets are small tablets. Bulk density of powders + 0.79 g/ml. 
450 mg / 0.79 g/ml = 0.57 ml 
0.5 cc = 0.5 ml used 
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                      TOP OF BOWL                     BOTTOM OF BOWL                    CENTRE OF BOWL                                    
 
Figure 3.3: Sampling points in bowl of Saral Rapid Mixer and wet granulator R&D model 
 
3.2.2.1 Sampling equipment 
A sampling thief with one disc was used for sampling of powders. All samples were taken by the 
researcher. This was to ensure sampling consistency. The correct volume insert was chosen.  
The volume insert was inserted into the lowest point of the inner rod of the sampling thief. The inner 
rod was slided into the outer sleeve. The angle of insertion of the sampling thief into the product was 
45 degrees and it was inserted slowly into the powder mixture. The handle was turned to expose the 
sampling cell to the product. The handle was turned so that no sampling inserts were exposed. The 
sampling thief was then removed from the product. The sample was placed into a bottle and placed 
onto the table from where the HPLC testing was performed. This was to avoid any further mixing that 
could have taken place. 
Literature suggests that this tool can be useful for free-flowing powders. Even though there are 
disadvantages to the sampling thief, it was chosen as the sampling equipment for these experiments 
as the same thief was used to sample all samples. It would be sufficient for the purpose of this 
project. The powders have proven to have enough flowability. Due to the fact that the variability for 
1 
2             3 
7 
4 
5             6 
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the % RSD among the three batches for each experiment were not extensive, also proves that the 
sampling was adequate for the study. Figure 3.4, 3.5 and 3.6 illustrate the sampling tool used. 
Figure 3.4: Sampling thief 
Figure 3.5: Sample insert into sampling thief 
Figure 3.6: Sketch showing how the sample thief works 
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3.2.3 Calculation of %RSD 
The 7 samples taken from each experiment from the three batches/ lots were assayed. The mean 
value and percentage Relative Standard Deviation (% RSD) was then calculated for each experiment. 
The USFDA issued a guidance for industry on ‘Powder blends and finished dosage units – stratified 
in-process dosage unit sampling and assessment’ (US Food and Drug Administration 2003). This 
guidance is intended to assist manufacturers of human drug products in meeting the requirements of 
21 CFR 211.110 for demonstrating the adequacy of mixing to ensure uniformity of in-process powder 
blends and finished dosage units. This guidance describes the procedures for assessing powder mix 
adequacy, correlating in-process dosage unit test results with powder mix test results, and 
establishing the initial criteria for control procedures used in routine manufacturing. The 
recommended criteria to use for a powder blend (in a blender) is to assay one sample per location 
(number of samples (n) > 10). The Relative Standard Deviation of all the individual results should be < 
5.0 %. All the individual results should be within  
10,0 % (absolute) of the mean results. Note that this is the criteria for a powder blend that could also 
be applied to the dry mix. 
 
3.2.4 Assay method for enalapril 
The USP method was used to assay the samples via High–Performance Liquid Chromatography. 
Chemical experiments in a laboratory represent one of the purest forms of experimental type research 
(Walliman 2005).  
Due to the fact that a USP method is used for the analysis, there was no need to perform a full 
validation on the method. USP methods are robust methods. Pharmacopoeial methods require partial 
validation (USFDA 2014). Partial validation included: system suitability and specificity. The method 
used is a stability indicating method. The method is hence capable of separating the API from 
impurities and degradation products. Specificity, System suitability, Linearity, Accuracy and Method 
precision were performed on this method. System suitability (precision) was tested during the 
experiments and passed during all testing that were performed for this project. 
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3.2.4.1 Apparatus and operating conditions 
The following instrument was used for testing of the samples:  
High-Performance Liquid Chromatograph (Waters Alliance HPLC System, 2695 Separations Module 
with a Waters 2487 Dual wavelength Absorbance Detector and Waters Alliance HPLC System, 2695 
Separation Module with a Waters 2489 dual wavelength absorbance detector, United States). 
The liquid chromatograph was equipped with a high pressure pump and a variable wavelength 
UV/VIS detector with the wavelength set at 215 nm. The auto-sampler on the equipment was set to 
inject 50 µl. The equipment has an integrator system. The column used was a Platinum EPS, C8 (5 
µm) (25 cm x 4,6 mm i.d.) column with a temperature at 50 °C. 
The following instrument was used for weighing of the samples: 
Balance (Mettler Toledo Top Loader balance and LC-P43 printer, Columbus) 
The following equipment was used for mixing and for weighing of powders: 
Measuring cylinders, volumetric flasks and beakers (Glassco Laboratory Equipments, India) 
 
The solvent consisted of a buffer solution, which is explained below. 
The mobile phase was as follows:  A mixture of acetonitrile (Merck, USA) : pH  2.2 buffer solution (25 :  
75), which was filtered and degassed. 
The buffer solution was prepared as follows: 1.38 g of monobasic sodium phosphate (Merck, USA)  
(Mw = 137.99 g/mol) was dissolved in 800 ml of water. The solution was adjusted with phosphoric  
acid (Merck, USA) to a pH of 2.2 and diluted with water to 1000 ml. It was then mixed. 
The mobile phase was prepared as follows: 250 ml of acetonitrile was mixed with 750 ml buffer. This  
mix was filtered and degassed.  
The flow rate used was 2.0 ml/min. Enough of the mobile phase was prepared for all samples tested. 
The amount was calculated for each sample using  +  50 ml of mobile phase. 
 
3.2.4.2 Preparation of standard solution 
The standard solution was prepared as follows: 
20 mg of enalapril maleate reference standard was weighed and put into a 100 ml volumetric flask. 
Solvent (buffer) was added to the flask and it was put in a sonicator and set to sonicate for 15  
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minutes. This solution was then allowed to cool down to room temperature. The solution in the flask 
was diluted to volume with solvent (buffer solution). 
NOTE: Due to reference standards being expensive, an in-house working standard was used. This 
working/secondary standard was qualified against the USP pharmacopoeia/primary standard. The 
standard used was within its expiry period and had dried basis assay of 100.0 % and as is assay of 
99.6 %. 
 
3.2.4.3 Preparation of recovery standard solution 
20 mg of enalapril maleate reference standard was weighed into a 100 ml volumetric flask.  Solvent 
(buffer) was added to the flask and it was put in a sonicator and set to sonicate for 15 minutes. This  
solution was then allowed to cool down to room temperature (21 degrees Celcius). The solution in the 
flask was diluted to volume with solvent. 
NOTE: The scales/balances used were calibrated and maintained according to standard operating 
procedures. 
 
3.2.4.4 Preparation of sample solution (for all 14 experiments’ samples) 
The sample solution (done for all 14 experiments’ samples-from 3 batches) was prepared as follows: 
150 mg of sample was added to each of the seven 100 ml volumetric flasks. 25 ml of solvent (buffer) 
was added to each flask and the flask was shaken manually. The solvent was then diluted to just 
below the neck of the flask. It was put in a sonicator and set to sonicate for 15 minutes. The solution 
was then allowed to cool down to room temperature. The solution in the flask was diluted to the mark 
with solvent and mixed well. 
 
3.2.4.5 Assay Procedure for enalapril 
Once all samples and the mobile phase were prepared, the equipment was set up.   
A run time of 10 minutes for the standard and the samples were employed. 
 
The HPLC column was equilibrated with the mobile phase for 30 minutes. The standard solution was  
injected five times and the average of the peak area results were calculated. 
A system suitability test was performed on the five standard injections and the parameters were  
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calculated and complied to the USP: the relative standard deviation of the peak areas due to the  
enalapril peak for 5 replicate injections was not more than 2 %. 
The recovery standard solution was injected twice and the recovery was calculated using the  
calculation for % Recovery Control (equation 1). The % recovery was between 98.0 – 102.0 % with  
respect to the enalapril peak. 
50 µl of the assay sample solution was injected twice and the average of the peak area results was 
calculated. The assay results were then calculated as specified in equation 2. 
The standard solution was injected twice at the end of the run. The relative deviation of the peak  
areas due to the enalapril peak for all standards was not more than 3.0 %. 
 
3.2.4.6 Calculations 
The calculations used were as follows: 
 
3.2.4.6.1. % Recovery Control 
% Recovery Control =  P rec x mass std x 100 Equation 1 
     P std x mass rec 
where: 
P rec = area of the relevant peak in the recovery standard solution 
P std = area of the relevant peak in the standard solution 
mass std = mass of relevant standard taken to prepare the standard solution, expressed in mg 
mass rec = mass of relevant standard taken to prepare the recovery standard solution, expressed in 
mg 
 
3.2.4.6.2 % m/m enalapril maleate 
% m/m enalapril maleate  
= the area of the enalapril peak in the sample solution x mass std x 50 x C x 100       Equation 2 
          the area of the enalapril peak in the standard solution x 100 x mass sam x 100 
 
where: 
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mass std = mass of enalapril maleate reference standard taken to prepare the standard solution, 
expressed in mg. 
C = potency of enalapril maleate reference standard, expressed as a percentage (100 %).  
 
3.2.4.7 Typical chromatograms 
Figure 3.7 illustrates a typical chromatogram for enalapril. The chromatogram was developed using 
the above chromatographic conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7: Chromatograms for enalapril 
 
The outcome was measured as % RSD of the 7 samples from the bowl per experiment, indicating the 
homogeneity of the blend. A lower % RSD is indicative of a more homogenous blend. The blend of 
the specific experiment is homogenous if the active content of all 7 assayed samples are within  
10 % of the mean results and the relative standard deviation (RSD) of the 7 results is less than or 
equal to 5 %. The target % m/m was either 0.20 %, 10.10 % or 20.00 %, depending on the 
experiment. 
 % RSD was calculated as per equation 3: 
 % Relative Standard Deviation = [(std deviation) / (mean)] x 100 %            Equation 3 
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The importance of each factor on homogeneity of the mix was established as well as the parameters 
(mixing speeds and time) that gave rise to a more homogenous mix.  
Results obtained could be used by the pharmaceutical company to compare to current parameters 
used in the pharmaceutical company. This data will be obtained from reports containing mixing 
parameters used for products mixed in this equipment. The outcome might be that the optimal mixing 
parameters are different from the current parameters in use, which can prompt the pharmaceutical 
company to change the parameters or to use different operating parameters for future products 
manufactured using this equipment. It might also be found that the parameters, which are currently 
used, are the optimal parameters, and then this study will serve as confirmation and a reference that 
can be used during future audits. It can also provide answers to possible audit questions and serve as 
proof to auditors that the parameters used have been well researched.  
The occupancy in a mixer/granulator bowl can be determined by using the bulk density for a powder 
sample. For this report we are only looking at enalapril maleate and lactose of constant bulk densities.  
 
3.3 Statistical analysis/data analysis 
A “screening design” refers to an experimental design that is applicable when a large number of 
potential causative factors need to be examined to find the most important few that may have an 
effect on one or more responses of interest. Screening designs may be derived from highly fractioned 
factorial designs. Plackett and Burman devised orthogonal arrays useful for screening that yield 
unbiased estimates of all main effects in the smallest design possible (Murphy 2010).  
Response surface methodology (RSM) was used to analyse the data. RSM is a collection of 
mathematical and statistical methods that are used to develop, improve or to optimize a product or 
process. It comprises of statistical experimental designs, regression modelling techniques, as well as 
optimization methods. The application of RSM involves experimental situations in which several 
independent variables potentially influence one (or more) response variable. The independent 
variables are controlled by the experimenter, in a designed experiment, whereas the response 
variable is an observed output of the experiment (Myers 2010). The designs have been developed by 
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the graphic software: The Essential Experimental Design© program EREGRESS Version 2.209 (2006-
Copyright). The statistical analyses of the measured response parameters have also been carried out 
with this software. 
 
3.4 Limitations of the design 
There are some downsides to the use of Plackett-Burman design and therefore this design can be 
used as a starting point. This design may be followed with more detailed experimentation.  Plackett-
Burman design is very helpful when one has a lot of potential factors and it needs to be established 
which are the vital few that will assist in solving problems and can be used to make decisions. This 
design is a useful tool to use when one wants to use design of experiments to learn as much as 
possible from the smallest amount of data. It is a tool that can be used to assist in ruling out the 
unimportant factors. It is often called a screening design. Once the significant factors have been 
established, the interaction between factors could be established by doing more experiments (eg. full 
factorial design). 
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4. RESULTS 
14 experiments were performed on three lots/batches of lactose and enalapril mixtures. Seven 
samples were taken from the bowl in duplicate during the different experiments and assay testing was 
performed on these samples. The percentage standard deviation was calculated for the assay results 
of the seven samples. The combination of results of seven samples with the lowest percentage 
relative standard deviation indicates the best mixing parameters for the dry mixing.  
Refer to Appendix B for all HPLC results obtained for all experiments and Appendix C for all results 
from all experiments. Table 4.2 outlines a summary of the results for the experiments. 
The % standard deviation for the output of the three batches varied from 0.43 – 23.53 %. 
The experiments with the lowest % RSD include: experiment 2 (1.71 %), experiment 8 (1.83 %), 
experiment 12 (2.45 %), experiment 4 (3.10 %), experiment 5 (3.19 %), experiment 11 (3.86 %), 
experiment 6 (4.30 %) and experiment 9 (10.70 %).  
The % RSD values for experiments 1 (62.33 %), 10 (52.11 %), 13 (59.06 %) and 14 (50.78 %) are the 
highest. 
The 2 centre points/ markers were experiments with numbers:  
- 4 and 6 (all factors are at their central values) and  
- 5 and 12. 
The results for these experiments are outlined in table 4.1. 
The % RSD values obtained for these markers are similar. This indicates repeatability/reproducibility 
of the project. Reproducibility is one component of the precision of a measurement or test method. 
Table 4.1: Experiment centre points 
Exp # Enalapril ratio, w/w Impeller, rpm Chopper, rpm Time, minutes % RSD 
4 10.10 125 1900 2 3.10 
6 10.10 125 1900 2 4.30 
5 20.00 200 1000 3.5 3.19 
12 20.00 200 1000 3.5 2.45 
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Table 4.2: Output for three batches 
Exp # 
Enalap
ril 
conc 
(%m/m) 
Impell
er 
Speed 
(rpm) 
Chopp
er 
Speed 
(rpm) 
Time 
(minut
es) 
% RSD for 7 samples  
Batch 1 Batch 2 Batch 3 
Average 
of three 
batches 
Std dev 
for 
%RSD 
of the 
three 
batches 
1 0.20 50 1000 0.5 54.09 % 88.88 % 44.03 % 62.33% 23.53% 
2 0.20 200 2800 3.5 2.75% 0.64% 1.75% 1.71% 
 
1.06% 
 
3 0.20 200 1000 0.5 21.76% 51.49% 34.88% 36.04% 
 
14.90% 
 
4 10.10 125 1900 2.0 2.39% 4.60% 2.31% 3.10% 
 
1.30% 
 
5 20.00 200 1000 3.5 2.28% 5.29% 1.99% 3.19% 
 
1.83% 
 
6 10.10 125 1900 2.0 4.69% 4.36% 3.84% 
 
4.30% 
 
 
0.43% 
 
7 0.20 200 2800 0.5 25.82% 24.80% 20.68% 
 
23.77% 
 
 
2.72% 
 
8 20.00 50 2800 3.5 1.43% 1.65% 2.41% 
 
1.83% 
 
 
0.51% 
 
9 0.20 50 2800 3.5 8.40% 7.99% 15.72% 
 
10.70% 
 
 
4.35% 
 
10 0.20 50 1000 3.5 44.78% 74.41% 37.14% 
 
52.11% 
 
 
19.69% 
 
11 20.00 200 2800 0.5 2.54% 3.35% 5.69% 
 
3.86% 
 
 
1.64% 
 
12 20.00 200 1000 3.5 2.10% 3.33% 1.92% 
 
2.45% 
 
 
0.77% 
 
13 20.00 50 1000 0.5 46.05% 63.10 % 68.03% 
 
59.06% 
 
 
11.53% 
 
14 20.00 50 2800 0.5 55.37% 48.60 % 48.37% 
 
50.78% 
 
 
3.98% 
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4.1 Statistical analysis 
The regression output for the model equation (equation 4) 
% RSD = b0 + b1*Concentration, %w/w + b2*Impeller, rpm + b3*Chopper, rpm + b4*Time, minutes 
          Equation 4 
is shown in table 4.3. 
From the p values in table 4.3, it is clear that there are three significant input variables (with p value < 
0.05). The order of significance from highest to lowest is: impeller blade speed, mixing time, chopper 
blade speed.  Concentration is not statistically significant. This confirms the findings made by the 
following researchers: 
- Kaufman in 1962: active concentration did not affect the homogeneity of a mix.  
- Venables & Wells in 2001: drug:excipient ratio has no effect. 
- Sudah et al. in 2002: the concentration of the active component did not affect the outcome of 
the mixing process. 
 
Backward elimination was performed, to eliminate the (not significant) concentration input variable. 
The results for the backward elimination are shown in table 4.4. 
The linear regression model equation is depicted in equation 5:  
%RSD = 85.30 – 0.184*Impeller – 0.01135*Chopper – 9.103*Time.               Equation 5 
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Table 4.3: Regression output for model % RSD = b0 + b1*Concentration, %w/w + b2*Impeller, rpm 
+ b3*Chopper, rpm + b4*Time, minutes 
Summary 
|R| 0.898 
R2 0.806 
R2 adjusted 0.720 
Standard Error 12.81 
# Points 14 
PRESS 2989.72 
R2 for Prediction 0.607 
Durbin-Watson d 2.242 
First Order Autocorrelation -0.217 
Collinearity 1.000 
Coefficient of Variation 56.891 
Precision Index 178.894 
ANOVA 
Source SS SS% MS F F Signif Df 
Regression 6136.3 81 1534.1 9.349 0.00289 4 
Residual 1476.8 19 164.09   9 
  LOF Error 1475.9 19  (100) 210.84 424.3032 0.00235 7 
  Pure Error 0.994 0  (0) 0.497   2 
Total 7613.2 100    13 
 
  p value Std Error -95% 95% t Stat VIF 
b0 90.87 
3.93454E-
05 12.21 63.24 118.50 7.440  
b1, Concentration -0.551 0.174 0.374 -1.396 0.294 -1.476 1.000 
b2, Impeller speed -0.184 0.00465 0.04931 -0.296 -0.07267 -3.736 1.000 
b3, Chopper speed -0.01135 0.02207 0.00411 
-
0.02064 -0.00205 -2.761 1.000 
b4, Mixing time -9.103 0.00498 2.465 -14.68 -3.526 -3.692 1.000 
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Table 4.4: Regression output for model %RSD = b0 + b1*Impeller,rpm + b2*Chopper,rpm 
b3*Time,minutes   
Summary 
|R| 0.871 
R2 0.759 
R2 adjusted 0.687 
Standard Error 13.54 
# Points 14 
PRESS 3266.21 
R2 for Prediction 0.571 
Durbin-Watson d 2.358 
First Order Autocorrelation -0.213 
Collinearity 1.000 
Coefficient of Variation 60.149 
Precision Index 20.187 
ANOVA 
Source SS SS% MS F F Signif Df 
Regression 5778.9 76 1926.3 10.50 0.00196 3 
Residual 1834.3 24 183.43   10 
  LOF Error 1590.4 21  (87) 318.08 6.5211 0.03016 5 
  Pure Error 243.88 3  (13) 48.78   5 
Total 7613.2 100    13 
 
  p value Std Error -95% 95% t Stat VIF 
b0 85.30 3.97015E-05 12.28 57.94 112.67 6.945  
b1 -0.184 0.00541 0.05213 -0.300 -0.06806 -3.534 1.000 
b2 -0.01135 0.02597 0.00434 -0.02102 -0.00167 -2.612 1.000 
b3 -9.103 0.00580 2.606 -14.91 -3.295 -3.492 1.000 
 
The data in table 4.4 is used for predicting the optimal values of the impeller blade and chopper blade 
speeds and mixing time to get the lowest %RSD.  
As one increases the time of mixing, the % RSD moves to a minimum. As the impeller speed 
increases, there is a slight decrease in the % RSD. As the chopper blade speed is increased, the % 
RSD also decreases slightly. The results suggest that if the impeller blade speed is set to its 
43 
 
maximum and the mixture is mixed for longer at a higher chopper blade speed, the more 
homogenous the resultant mixture will be. 
Table 4.5: Optimal input parameters to achieve the minimum % RSD 
Term Impeller,rpm Chopper, rpm Time,minutes 
Data Min 50 1000 0.5 
Data Avg 125 1900 2 
Data Max 200 2800 3.5 
Cur Value 191 2002 3.01 
   The % RSD for the Current Values (which were adjusted to give a minimum %RSD) in table 4.5 is 
0.007462 %. 
4.1.1 Statistical Significance 
To determine if the regression model fits (the whole model) is statistically significant; a statistical test 
must be conducted. In this case the F-test.  
A probability value (p-value) is produced which indicates statistical significance if this calculated p-
value is smaller than 0.05.     
4.1.1.1 The overall model: 
The p-value from the F-test is less than 0.05(F3,13=10.50;p=0.00196) indicating a significant fit of the 
model at a 95% level of confidence. 
The equation that fits this model is shown in equation 6.
%RSD = 85.30 – 0.184*Impeller – 0.01135*Chopper – 9.103*Time         Equation 6 
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4.1.1.2 Individual predictors: 
To assess the significance of the individual independent variables, t-tests and the individual p-values 
were be used.   
The input factor impeller blade speed has a statistically significant influence on % RSD at a 95% level 
of confidence with a p-value below 0.05(t=-3.34; p=0.00541).  The input factor Time also has a 
significant influence on %RSD at a 95% level of confidence with a p-value below 0.05(t=-3.492; 
p=0.00580) as well as the input factor chopper blade speed below 0.05(t=-2.612; p=0.02597). The 2 
factors that have the most significant impact on the end result were impeller speed and mixing time, 
as the p-value for these two parameters are much smaller than that for the chopper blade speed. 
 
4.1.2 Response surface plots 
Response surface plots were drawn up in figures 4.1 – 4.3 which show the relationships between the 
statistical significant parameters. 
 
Figure 4.1: Response surface plot of estimated effects of mixing time and impeller blade speed  
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 Figure 4.2: Response surface plot of estimated effects of mixing time and chopper blade speed 
 
 
Figure 4.3: Response surface plot of estimated effects of chopper blade and impeller blade speeds 
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From figure 4.1 it is clear that as the mixing time and impeller blade speed is increased, the % RSD 
becomes smaller, which indicates a more homogenous mix is produced. When the mix is mixed for a 
longer time, the powders are mixed in the mixer bowl for longer, which produces a mix that is more 
homogenous. The samples tested from the bowl therefore have assay results with values close to 
each other. The % RSD for the seven samples taken from the bowl is hence lower. With an impeller 
blade speed that is higher, the development of slip planes within a bed of materials or the splitting of 
the bed of material to disintegrate agglomerates to overcome cohesion happens at a faster rate and 
therefore more slip planes are formed in a shorter amount of time which results in mixing of powders 
taking place faster. With a low impeller blade speed, the slip planes in the mix will form at a slower 
rate. It takes longer for the powders to be mixed homogenously. The % RSD value in the plot 
decreases from 40.0 - 50.0 % RSD to -10.0 - 0.0 % with the impeller blade speed and mixing time at 
its highest values on the plot. 
The % RSD is higher with impeller blade speed and mixing time at its lowest (figure 4.1) compared to 
the chopper blade and mixing time at its lowest settings (figure 4.2). This indicates that the mixer 
speed has a bigger impact on the homogeneity of the mix. 
From figure 4.2 it is clear that as mixing time and chopper blade speed are increased, the % RSD 
becomes smaller, which is indicative of a more homogenous mix. This plot reiterates the data on 
mixing time in figure 4.1. With a higher chopper blade speed, agglomerates of powders are broken 
down at a faster rate and the powders can mix faster. The % RSD value in the plot decreases from 
40.0 - 50.0 % RSD to -10.0 - 0.0 % with the chopper blade speed and mixing time at its highest 
values on the plot. 
From figure 4.3 it is clear that as impeller blade and chopper blade speeds are increased, the % RSD 
becomes smaller, which is indicative of a more homogenous mix. The % RSD value in the plot 
decreases from 35.0 - 40.0 % RSD to -5.0 - 0.0 % with the chopper blade speed and impeller blade 
speed set at its highest values on the plot. 
The % RSD value is the highest in figure 4.1, which may indicate that the combination of impeller 
speed and mixing time has the most significant impact on the % RSD result. 
During the mixing process slip planes are formed within the bed of materials by the impeller blade and 
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agglomerates are disintegrated to overcome cohesion forces between particles. Agglomerates are 
broken down also by the chopper blade. Powders are hence mixed as it is moved through the mixing 
bowl. 
4.1.3 Measures of model fit 
The coefficient of determination (R2): This value indicates how well the regression model fits the data. 
The R2 adjusted value for the regression analysis was 0.687. This indicated that 68.7 % of variation in 
% RSD is explained by the regression model.  
4.1.4 Model adequacy graphs 
Figure 4.4 and table 4.6 depict the actual % RSD vs. the predicted % RSD (from the model). The 
residuals or errors were calculated from equations 7 and 8.  
Actual values – fitted model = residuals           Equation 7 
% RSD – fitted % RSD (model) = residuals.            Equation 8 
This model indicates that the results for the predicted % RSD fit the actual % RSD data quite 
adequately. 
Figure 4.4: Comparison of the actual % RSD vs the predicted % RSD. 
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Table 4.6: Comparison of the actual % RSD vs the predicted % RSD with the 95 % confidence 
intervals 
Exp # %RSD Predicted %RSD +95 % Confid Int Pred -95 % Confid Int Pred 
1 62.33 60.20 94.89 25.51 
2 1.71 -15.16 19.52 -49.85 
3 36.04 32.57 67.25 -2.124 
4 3.1 22.52 53.75 -8.719 
5 3.19 5.257 39.95 -29.43 
6 4.3 22.52 53.75 -8.719 
7 23.77 12.14 46.83 -22.55 
8 1.83 12.47 47.16 -22.22 
9 10.7 12.47 47.16 -22.22 
10 52.11 32.89 67.58 -1.800 
11 3.86 12.14 46.83 -22.55 
12 2.45 5.257 39.95 -29.43 
13 59.06 60.20 94.89 25.51 
14 50.78 39.78 74.46 5.086 
The 95 % confidence interval prediction values indicate the % RSD results range for a specific 
experiment’s operating parameters for which one could be 95 % certain that the predicted value 
would be accurate. 
The residual values indicate the difference between the actual and predicted value. 
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Figure 4.5: Model indicating the residuals 
Table 4.7: Table indicating the actual % RSD vs the residuals 
Exp # % RSD Residuals 
1 62.33 2.133 
2 1.71 16.87 
3 36.04 3.474 
4 3.1 -19.42 
5 3.19 -2.067 
6 4.3 -18.22 
7 23.77 11.63 
8 1.83 -10.64 
9 10.7 -1.767 
10 52.11 19.22 
11 3.86 -8.284 
12 2.45 -2.807 
13 59.06 -1.137 
14 50.78 11.00 
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4.1.5 Aliasing 
Main effects are not aliased with each other but all main effects are aliased with all two way 
interactions. 
4.2 Limitations 
Problems were encountered with the model fit especially at 2 minutes and impeller blade speed set at 
125 rpm, which is a limitation. The 2 minutes mixing time and impeller blade rpm could be increased 
in future studies in which a factorial design is used. This would then lead to a narrowing of the 
variation in the design of the experiment and allow the researcher to obtain actual values for the 
specific mixing equipment they are using. 
The modelling in EREGRESS accounts for the experimental design. The problems with the 
converging with the fit are a limitation and the research is only exploratory to determine if the tested 
factors had an influence. Now that the influence of the various input factors is known, future research 
in the area of mixing of small amounts of API’s could explore a larger range of formulations with a 
narrowing of the experimental values to obtain the actual quantitative effect on the setting for the 
operating parameters of the mixing equipment used.   
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5. DISCUSSION AND RECOMMENDATIONS 
5.1 Discussion  
The output (% RSD) from the different experiments amongst the three batches varied. The % 
standard deviation for the output of the three batches varied from 0.43 – 23.53 %. The result for % 
RSD obtained among the three batches were similar in most of the experiments indicating that the 
sampling method was also adequate. Experiments performed by Muzzio et al. (1999) showed that 
insertion of the side-sampling thief created significant disturbances in the mixture. Particles from 
upper layers were dragged deeply into lower layers as the thief penetrated the granular bed. The thief 
also had particles from all positions along the path of insertion and did not necessarily reflect the true 
composition of the system at the intended sampling location. As all the experiments for all three 
batches had been sampled the same way, this sampling method was adequate for the project. Future 
research could be performed on on-line technology – near infrared (NIR) – in the determination of 
homogeneity of dry powders during the dry mixing step in high shear mixer/granulators. The use of 
this technology has been explored in blenders. NIR can determine the homogeneity of dry powder 
blending online (Wechsler 2002). 
The higher deviation among the results for the three batches was for the experiments where three or 
four of the parameters were at low settings (experiments 1, 3, 10, 13). The % RSD was above 10.00 
%. The high variability for these experiments is due to inadequate mixing which results in high 
variability among the three batches.  
For the other experiments the % standard deviation for the results obtained from the three batches 
were < 4.50 %. 
The experiments where medium or high mixer blade speed and/or mixing time was used all passed 
the criteria of having a % RSD < 5 % for the average of the three batches (experiments 2, 4, 5, 6 and 
12). For these experiments the results also pass the criteria of the 7 individual results being within 10 
% of the average results. There are 2 experiments that have a % RSD of less than 5 % and have a 
low mixer speed or mixing time, but have a high concentration of enalapril. These are experiments 8 
and 11. Experiment 10 had a very high % RSD and had the following settings: a low mixer speed, 
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high mixing time, but a low concentration. It is therefore clear that adequate mixing is easier to 
achieve when the drug loading is higher.  
The combination of parameters used in experiments 1, 13 and 14 were inadequate and hardly any 
mixing took place. The mixing time and impeller blade speed were at the lower settings. 
The % RSD values for the 2 centrepoints, which are experiments with the same operating 
parameters, were similar. The same operating parameters hence produced almost the same result 
when repeated. 
 
From the plots in figures 4.1 to 4.3 and the results in table 4.2 it is clear that: 
(a) As the mixing time and impeller blade speed increases, the mixture becomes more even as 
the % RSD becomes lower.  In figure 4.1, the % RSD goes into a negative. These two 
parameters were proven to have the biggest impact on the outcome of the efficiency of the 
mixture, as will be explained later. 
(b) As the mixing time and chopper blade speed increases, the mixture becomes more even as 
the % RSD becomes lower.  
(c) As the impeller and chopper blade speeds increase, the mixture becomes more even as the 
% RSD becomes lower. The lower the % RSD, the more even the distribution of the enalapril 
powder throughout the mix.  
(d) As the impeller blade speed increases, the mixture becomes more even as the % RSD 
becomes lower. This is applicable to low, medium and high percentages of enalapril in the 
mixture. 
(e) As the chopper blade speed increases, the mixture becomes more even as the % RSD 
becomes lower. This is especially evident in the experiments with a high percentage of 
enalapril in the mixture. 
(f) As the mixing time increases, the mixture becomes more even as the % RSD becomes lower. 
This is more evident in the experiments with high percentage of enalapril in the mixture. In the 
experiments with low percentage of enalapril in the mixture, it is clear that increasing the 
mixing time alone does not positively impact on the mix uniformity. In this case main impeller 
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blade and chopper blade speeds are also important, as the percentage of enalapril powder in 
the mixture is very low. 
 
The Pearson correlation coefficient is equal to 89.8 % for the regression output model for all four 
parameters, which is close to a total positive correlation.  
From the statistics in table 4.3, it can be seen that the p value for the chopper blade speed (0.02207), 
impeller blade speed (0.00465) and mixing time (0.00498) is less than 0.05, which makes these three 
parameters significant. The concentration is insignificant as the p value for this parameter is 0.174.  
The impeller blade speed and mixing time are the two parameters that are the most significant, 
followed by the chopper blade speed.  
Backward elimination was performed and statistics were done for the three significant parameters. 
 
From table 4.4 the following can be concluded: 
The Pearson correlation coefficient is equal to 87.1 %. There is a good degree of linear dependence. 
The p-value from the F-test is less than 0.05(F3,13=10.50;p=0.00196) indicating a significant fit of the 
model %RSD = 85.30 – 0.184*Impeller – 0.01135*Chopper – 9.103*Time at a 95% level of 
confidence.  
The student t test and individual p values indicate the significance of the individual independent 
variables. The factor impeller blade has significant influence on % RSD at a 95% level of confidence 
with a p-value below 0.05(t=-3.534; p=0.00541).  The factor chopper also has significant influence on 
% RSD at a 95 % level of confidence with a p-value below 0.05(t=-2.612; p=0.02597). The factor 
Time also has significant influence on % RSD at a 95 % level of confidence with a p-value below 
0.05(t=-3.492; p=0.00580). 
There is a reasonable correlation between the actual and predicted values from the regression model 
(R = 0.871). The coefficient of determination (R2) indicates how well the regression model fitted the 
data. In this case the R2 value is 0.687. This indicated that 68.7 % of variation in % RSD is explained 
by the regression model. Please note that the adjusted R2 value must be used if there is more than 1 
independent variable as in this case.  
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The optimal parameters indicated are: impeller blade speed set at 191 rpm, chopper blade speed set 
at 2002 rpm and mixing time set at 3.01 minutes. The % RSD is very low at these parameters 
(0.007462 %). 
The actual % RSD vs the predicted % RSD values are reasonably close, except for three of the 
experiments (4, 6 and 10). Experiments 4 and 6 had all the medium parameters and experiment 10 
had low parameters for enalapril ratio, impeller blade speed and chopper blade speed. 
The actual % RSD values obtained for the experiments and the predicted % RSD values are similar. 
The residuals for the actual vs. the predicted results are between 1.137 and 19.42. The model can 
hence predict optimal parameters with good confidence. In table 4.6 the range of % RSD values for 
which one could be 95 % confident that the value could be correct for a certain set of operating 
parameters is provided.  For the parameters used in experiment 1 for example, if the % RSD falls 
between 25.51 and 94.89 one could be 95 % confident that that could be the value one would obtain 
for such experiment. From figure 4.5 it is evident that the residuals are lower for predicted %RSD 
values of between 0 and 10 % and between 50 and 70 %. In between these predicted %RSD values 
the residual is higher. This is preferred as one could be certain that the experiments which give very 
bad or very good mixing, can be predicted with more certainty as the residual between the actual and 
predicted values are lower. The predicted values will hence be close to the actual value. 
 
Other approaches may have produced similar results. An experiment was conducted to compare a full 
factorial experiment with a Plackett-Burman design. For the full factorial design 32 experiments had to 
be performed compared to the 12 for the Plackett-Burman Design. The same factors showed up as 
significant. The full factorial design indicated the significant interactions whereas the Plackett-Burman 
design could not do that. The factor settings and conclusion remained the same when either design 
was used. There is however a significant difference in the number of experiments that needs to be 
conducted (Jayakumar 2013). For the purpose of this project, a Plackett-Burman design was sufficient 
as it provided a rough estimate of the main effects. Given the number of parameters and levels of 
these, a Plackett-Burman design was chosen for this project. With only a limited amount of 
experiments that had to be conducted, the necessary conclusions could be drawn. 
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5.2 Conclusions 
Data on dry mixing in a high shear mixer is limited. This includes optimal parameters to be used as 
well as criteria for homogeneity.  
By performing the dry mixing step and granulation in one piece of equipment saves time and therefore 
money. The equipment used is a high shear mixer instead of a blender for mixing and a high shear 
mixer for granulation. 
As there are many parameters to be controlled during dry mixing in a high shear mixer, a statistical 
design method is suitable to establish the parameters that would have the most impact on the end 
result. After establishing this, further experimentation could be done to ensure that all the raw 
materials are evenly distributed at the dry mixing stage, ensuring the uniformity of the active 
pharmaceutical ingredient(s) and inactive pharmaceutical ingredient(s) in granules, before blending 
and compression. By using Design of Experiments, the industry could make more informed decisions 
when it comes to risk. By having a better understanding of the possible impact of, for example, a 
higher mixing speed and having results from this project to see the impact of a higher mixing speed, 
the risk to the final product of using a higher or lower mixing speed with the powders prior to 
granulation could be predicted with more confidence. These experimental results could be used 
during audits by external auditors as part of the data generated during the development of the product 
and to prove how the dry mixing parameters were established. Design of experiments is a tool that 
could be utilised much more during the development stage of products and during problem solving in 
production. The Plackett-Burman design is a tool that gives a lot of data with minimal experiments 
performed. The use of statistical design methods has demonstrated various advantages in previous 
studies. Four factors were investigated. These four factors were chosen based on literature data and 
experience. 
 
Statistically it was found that mixing speed of the main impeller blade and chopper blade and overall 
mixing time are the three factors that have the biggest impact on the homogeneity of a mixture. These 
three parameters would thus be critical for process validation. The mixing time and impeller blade 
speed have proven to be more significant than the chopper blade speed.  
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Concentration was found to be insignificant and this is similar to the findings made by Kaufman in 
1962 (active concentration did not affect the homogeneity of a mix), Venables & Wells in 2001 (drug 
content variation increases with decreasing drug content, but drug:excipient ratio has no effect) and 
Sudah et al. in 2002 (the concentration of the active component did not affect the outcome of the 
mixing process). 
For our experiments and for the specific granulator used the following optimal parameters could be 
deduced: Impeller blade speed set at 191 rpm, chopper blade speed set at 2002 rpm and mixing time 
set at 3.01 minutes.  
 
The experiments where medium or high mixer blade speed and/or mixing time were used also passed 
the criteria of having a % RSD < 5 % as well as individual results within 10 % of the mean result 
obtained. 
 
I have thus achieved the aim of the study to determine the most significant parameters during mixing 
as well as optimal settings for dry mixing parameters in a high shear mixer/granulator. 
Experimental design usage in pharmaceutical development, especially initial mixing, has great 
potential for further investigation to establish which are the factors for a specific active ingredient that 
have the biggest effect on optimal mixing.  
 
5.3 Recommendations 
Areas of possible future research that became evident through this study are: 
- To explore the impact of moisture on the effectiveness of mixing. 
- To explore the impact of different particle sizes of the Active Pharmaceutical Ingredient on the 
effectiveness of mixing using design of experiments. 
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- An evaluation of a number of other variables such as loading capacity, evaluation of other 
sample thief designs and extended mixing times on blend uniformity. 
- Explore the possibility of using near infrared technologies for the determination of 
homogeneity of a dry mix in a high shear mixer/granulator. 
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